CIPOLLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.392
EU - Europa 1.936
AS - Asia 1.511
SA - Sud America 229
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 43
OC - Oceania 4
Totale 6.184
Nazione #
US - Stati Uniti d'America 2.329
RU - Federazione Russa 804
SG - Singapore 535
CN - Cina 471
GB - Regno Unito 379
IT - Italia 215
BR - Brasile 170
VN - Vietnam 166
HK - Hong Kong 111
SE - Svezia 99
DE - Germania 89
FR - Francia 88
IE - Irlanda 77
FI - Finlandia 72
KR - Corea 59
BD - Bangladesh 49
CA - Canada 35
IN - India 27
JP - Giappone 19
EC - Ecuador 18
NL - Olanda 18
ID - Indonesia 17
AR - Argentina 16
BE - Belgio 16
ES - Italia 16
MX - Messico 15
ZA - Sudafrica 15
PL - Polonia 14
UA - Ucraina 13
TR - Turchia 11
NG - Nigeria 9
AT - Austria 8
CO - Colombia 7
PK - Pakistan 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
IQ - Iraq 6
PY - Paraguay 6
BJ - Benin 5
AU - Australia 4
CH - Svizzera 4
CL - Cile 4
JM - Giamaica 4
LT - Lituania 4
MA - Marocco 4
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
TG - Togo 3
BG - Bulgaria 2
EG - Egitto 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
UY - Uruguay 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
YT - Mayotte 1
Totale 6.116
Città #
Ashburn 308
Dallas 304
Southend 303
Singapore 278
Moscow 275
Chandler 248
San Jose 242
Beijing 112
Hong Kong 109
Woodbridge 91
Ann Arbor 87
Verona 85
Council Bluffs 83
Dublin 77
The Dalles 69
Jacksonville 59
New York 59
Ho Chi Minh City 50
Los Angeles 46
Houston 44
Hanoi 39
Helsinki 39
Nanjing 36
Munich 29
Lawrence 28
Princeton 28
Santa Clara 28
Jinan 27
Buffalo 24
Shenyang 24
Seoul 23
Wilmington 22
São Paulo 19
Tokyo 18
Milan 16
Brussels 14
Hebei 14
Amsterdam 13
Changsha 13
Montreal 12
Warsaw 12
Chicago 11
Columbus 11
Dong Ket 11
Jakarta 11
Johannesburg 11
London 11
Denver 10
Redondo Beach 10
Taizhou 10
Turku 10
Abuja 9
Ankara 9
Boardman 9
Bologna 9
Chennai 9
Nanchang 9
Ningbo 9
Stockholm 9
Brooklyn 8
Frankfurt am Main 8
Haikou 8
Orem 8
Seattle 8
Tianjin 8
Rome 7
San Francisco 7
Sindelfingen 7
Tashkent 7
Zhengzhou 7
Atlanta 6
Falkenstein 6
Ferrara 6
Hangzhou 6
Jiaxing 6
Norwalk 6
Quito 6
Toronto 6
Vienna 6
Asunción 5
Brasília 5
City of London 5
Cotonou 5
Falls Church 5
Guangzhou 5
Guayaquil 5
Hải Dương 5
Lanzhou 5
Lappeenranta 5
Mexico City 5
Osasco 5
Phoenix 5
Redwood City 5
Rio de Janeiro 5
Taiyuan 5
Washington 5
Auburn Hills 4
Baghdad 4
Boston 4
Haiphong 4
Totale 3.823
Nome #
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. 292
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 211
Ataluren-driven Restoration of Shwachman-Bodian-Diamond Syndrome Protein Function in Shwachman-Diamond Syndrome Bone Marrow Cells 207
Further characterization of Shwachman-Diamond syndrome: psychological functioning and quality of life in adult and young patients. 202
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series 193
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. 187
Further Insights into the Hematological Disorders Observed in Shwachman-Diamond Syndrome: mTOR and STAT3 Hyper-Phosphorylation in CD4+ and CD8+ T Cells and Efficacy of Rapamycin Treatment 187
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 187
Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome 183
291 Colon cancer screening program in adult CF patients: an Italian cross-sectional pilot study 182
Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. 176
Identification of novel mutations in patients with Shwachman-Diamond syndrome 172
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome 171
A Prospective Study of Hematologic Complications and Long-Term Survival of Italian Patients Affected by Shwachman-Diamond Syndrome 169
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 168
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 167
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 165
Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. 163
GENETIC ANALYSIS OF THE SBDS GENE AMONG NON-ITALIAN PATIENTS 160
A Prospective Haematological Survey Of Italian Patients Affected By Shwachman-Diamond Syndrome: Results Of A Ten Years Multicentric Study 159
Shwachman-Diamond syndrome 154
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 148
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 147
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 146
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 139
Celiac disease and obesity: need for nutritional follow-up after diagnosis. 139
Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability 137
Mutation Screening of Elongation Factor 2 in Shwachman-Diamond Syndrome Patients Lacking Mutations in the SBDS Gene 136
Novel Translational Read-Through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome 135
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 134
Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old 134
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 130
Efficacy of Elexacaftor–Tezacaftor–Ivacaftor on chronic rhinosinusitis in cystic fibrosis 121
Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond Syndrome carrying biallelic SBDS mutations 121
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes 119
Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia 105
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 98
Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients 95
The Gluten Free Diet's Impact on Growth in Children with Celiac Disease in Two Different Countries 91
Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program 42
Beyond readthrough: ataluren restores mitochondrial function and reduces oxidative stress in FANCA-mutated cells via mTOR–DRP1 modulation 12
Totale 6.184
Categoria #
all - tutte 20.713
article - articoli 19.161
book - libri 0
conference - conferenze 1.552
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022123 0 0 0 11 7 3 4 15 7 6 17 53
2022/2023587 32 81 42 113 48 134 4 32 68 8 15 10
2023/2024307 9 23 21 37 33 47 11 32 7 28 42 17
2024/2025852 34 30 36 164 36 33 44 32 150 38 71 184
2025/20262.912 146 155 314 510 685 176 252 153 209 167 64 81
2026/2027324 38 60 75 151 0 0 0 0 0 0 0 0
Totale 6.184